TP53 and skin neoplasm: The risk of skin cancers in LFS patients was first detailed in a study of 71 unselected TP53 mutation carriers, which revealed a significantly greater cumulative risk of BCC and MM than did the general Dutch population, although SCC risk was not assessed due to the limited number of cases.